Gilles Uze
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state.
Journal: Molecular cancer
Published: August 13, 2023
A loss-of-function IFNAR1 allele in Polynesia underlies severe viral diseases in homozygotes.
Journal: The Journal of experimental medicine
Published: January 05, 2022
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication.
Journal: Journal for immunotherapy of cancer
Published: October 17, 2021
Targeting IFN activity to both B cells and plasmacytoid dendritic cells induces a robust tolerogenic response and protection against EAE.
Journal: Scientific reports
Published: July 09, 2021
An Old Cytokine Against a New Virus?
Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
Published: June 26, 2020
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant.
Journal: NPJ vaccines
Published: September 17, 2019
Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice.
Journal: Journal of autoimmunity
Published: September 11, 2018
Signal Propagation in Sensing and Reciprocating Cellular Systems with Spatial and Structural Heterogeneity.
Journal: Bulletin of mathematical biology
Published: October 26, 2017
Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.
Journal: The Journal of cell biology
Published: May 27, 2015
Last Updated: 09/26/2026